Table 2. Cost benchmarks for the 12 countries of known endemicity.
| Economic | Financial | |||||
| Best | Low | High | Best | Low | High | |
| Drugs | 28 | 22 | 34 | 28 | 22 | 34 |
| Diagnostics | 0.7 | 0.4 | 1.1 | 0.7 | 0.4 | 1.1 |
| Delivery | 314 | 31 | 1008 | 193 | 57 | 503 |
| Clinical surveillance | 19 | 11 | 29 | 19 | 11 | 29 |
| Total | 362 | 75 | 1073 | 241 | 100 | 557 |
| Total (excl. drugs) | 334 | 48 | 1038 | 213 | 74 | 522 |
Best estimates with 5th and 95th centiles, 2015 US$ millions*.
*See Supporting Information for the studies and regression models used to estimate economic and financial unit costs. The difference between economic and financial costs is explained in the methods.